Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) is anticipated to announce its results before the market opens on Tuesday, August 18th. Analysts expect the company to post earnings of $0.9330 per share and revenue of $1.1069 billion for the quarter.
Coloplast A/S Price Performance
Shares of CLPBF opened at $65.29 on Tuesday. Coloplast A/S has a 1-year low of $56.81 and a 1-year high of $98.58. The firm’s 50 day simple moving average is $60.56 and its 200 day simple moving average is $66.95.
Coloplast A/S Company Profile
Coloplast A/S is a Denmark‐based medical device company specializing in the development and manufacturing of products and services for people with intimate healthcare needs. Founded in 1957 by Aage Louis‐Hansen and Poul Mollgaard Jensen, the company set out to improve quality of life for patients requiring ostomy care, and has since expanded into multiple clinical areas. Coloplast is headquartered in Humlebæk, Denmark, and combines in‐house research and development with strategic partnerships to drive innovation in its core markets.
The company’s product portfolio is organized around four primary areas: ostomy care, continence care, wound and skin care, and interventional urology.
Featured Stories
- Five stocks we like better than Coloplast A/S
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
